Serum β-Trace Protein and Risk of Mortality in Incident Hemodialysis Patients | Zendy

Tariq Shafi | Zendy; Rulan S. Parekh | Zendy; Bernard G. Jaar | Zendy; Laura Plantinga | Zendy; Pooja C. Oberai | Zendy; John H. Eckfeldt | Zendy; Andrew S. Levey | Zendy; Neil R. Powe | Zendy; Josef Coresh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum β-Trace Protein and Risk of Mortality in Incident Hemodialysis Patients

Author(s) -

Tariq Shafi,

Rulan S. Parekh,

Bernard G. Jaar,

Laura Plantinga,

Pooja C. Oberai,

John H. Eckfeldt,

Andrew S. Levey,

Neil R. Powe,

Josef Coresh

Publication year - 2012

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02240312

Subject(s) - medicine , hazard ratio , dialysis , renal function , hemodialysis , proportional hazards model , prospective cohort study , confidence interval , cohort study , creatinine , kidney disease , cohort

Residual kidney function in dialysis patients is associated with better survival, but there are no simple methods for its assessment. β-Trace protein is a novel endogenous filtration marker of kidney function that is not removed during hemodialysis and may serve as a marker for residual kidney function similar to serum creatinine in patients not on dialysis. The objective of this study was to determine the association of serum β-trace protein with mortality in incident hemodialysis patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research